Michael Hallek to Deubiquitinating Enzyme CYLD
This is a "connection" page, showing publications Michael Hallek has written about Deubiquitinating Enzyme CYLD.
Connection Strength
0.179
-
Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-?B signaling. Leukemia. 2018 01; 32(1):72-82.
Score: 0.179
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.